Evidence map›Paper›PMID 37875923›Full record

ArticleAnnals of clinical microbiology and antimicrobials2023

Positive Francisella tularensis meningitis outcome despite delayed identification: a case report.

Vesa Mäki-Koivisto, Marianne Korkala, Lotta Simola, Sonja Suutari-Kontio, Sini Koivunen, Teija Puhto, Ilkka S Junttila

Open access · goldAbstract readCase Reports
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Tularemia Antimicrobial Treatment and Prophylaxis: CDC Recommendations for Naturally Acquired Infections and Bioterrorism Response - United States, 2025.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2025
    Guideline
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Vesa Mäki-KoivistoNordLab, Oulu, Finland. vesa.maki-koivisto@nordlab.fi.
Marianne KorkalaNordLab, Oulu, Finland.
Lotta SimolaOulu University Hospital, Oulu, Finland.
Sonja Suutari-KontioNordLab, Oulu, Finland.
Sini KoivunenNordLab, Oulu, Finland.
Teija PuhtoOulu University Hospital, Oulu, Finland.
Ilkka S JunttilaNordLab, Oulu, Finland. ilkka.junttila@tuni.fi.
NordLab · FIOulu University Hospital · FIUniversity of Oulu · FI

Funding

Academy of Finland 25013080481Compentitive State Research Financing of the Expert responsibility Area of Fimlab X51409Nordlab Laboratories X3710-KT0011
6 · The paper itself

Abstract

Francisella tularensis is a Gram-negative bacteria, that may cause a zoonotic disease, tularemia. Here, we describe a patient case, where a previously healthy young woman in Northern Finland contacted health care because of fever and headache. Due to the symptoms and lack of further diagnostic tools in primary health care, she was transferred to University Hospital (UH) where ampicillin and ceftriaxone was given empirically. A cerebrospinal fluid sample (CSF) was drawn showing small Gram-negative rods that grew on chocolate agar after 2 days of incubation. Matrix-assisted laser-desorption-ionization time of-flight (Maldi-tof) did not provide identification, but the bacteria was interpreted as sensitive to ciprofloxacin and the treatment was changed to ciprofloxacin. During the time the patient was infected, there were several positive tularemia samples found in the area. Therefore, an in house tularemia nucleic acid method (PCR) was used on the bacterial culture. Additionally, 16S rDNA sequencing was performed and these methods identified the bacteria as F. tularensis. Fortunately, the patient recovered completely with ciprofloxacin and was discharged without any complications. Our case underlines the need to understand the limits of specific diagnostic methods, such as Maldi-tof, used in clinical laboratory settings. It also highlights the need of both clinicians and laboratory staff to be aware of the many clinical presentations of tularemia when working in an endemic area.

Indexed as

Francisella tularensisMeningitisTularemiaCiprofloxacinFemaleHumansPolymerase Chain ReactionCiprofloxacinCiprofloxacinFrancisella tularensisMaldi-tofMeningitisPCR

Identifiers

PMID37875923
PMCPMC10598999
OpenAlexW4387907756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.